| Basal insulin and cardiovascular and other outcomes in dysglycemia. YS ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R ... N Engl J Med 367 (4), 319-328, 2012 | 2014 | 2012 |
| n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. YS ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R ... N Engl J Med 367 (4), 309-318, 2012 | 1106 | 2012 |
| Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study K Khunti, S Alsifri, R Aronson, M Cigrovski Berković, C Enters‐Weijnen, ... Diabetes, obesity and metabolism 18 (9), 907-915, 2016 | 283 | 2016 |
| Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes K Khunti, S Alsifri, R Aronson, MC Berković, C Enters-Weijnen, T Forsén, ... diabetes research and clinical practice 130, 121-129, 2017 | 78 | 2017 |
| nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma S Kapitanović, T Čačev, M Berković, M Popović-Hadžija, S Radošević, ... Journal of clinical pathology 57 (12), 1312-1318, 2004 | 75 | 2004 |
| Hrvatske smjernice za farmakološko liječenje šećerne bolesti tipa 2 D Rahelić, V Altabas, M Bakula, S Balić, I Balint, B Bergman Marković, ... Liječnički vjesnik 138 (1-2), 1-21, 2016 | 68* | 2016 |
| Psoriasis severity—a risk factor of insulin resistance independent of metabolic syndrome MV Polic, M Miskulin, M Smolic, K Kralik, I Miskulin, MC Berkovic, ... International journal of environmental research and public health 15 (7), 1486, 2018 | 49 | 2018 |
| NAFLD and Physical Exercise: Ready, Steady, Go! M Cigrovski Berkovic, I Bilic-Curcic, M A, C V Frontiers in nutrition, 2021 | 38 | 2021 |
| IL-2− 330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs) M Cigrovski Berković, M Jokić, J Marout, S Radošević, V Zjačić-Rotkvić, ... Journal of molecular medicine 88, 423-429, 2010 | 38 | 2010 |
| IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs) MC Berković, M Jokić, J Marout, S Radošević, V Zjačić-Rotkvić, ... Experimental and molecular pathology 83 (3), 474-479, 2007 | 37 | 2007 |
| Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients MC Berkovic, I Bilic-Curcic, LLG Sabolic, A Mrzljak, V Cigrovski World journal of diabetes 12 (5), 569, 2021 | 34 | 2021 |
| New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors M Cigrovski Berkovic, T Cacev, T Catela Ivkovic, V Zjacic-Rotkvic, ... Neuroendocrinology 99 (2), 75-84, 2014 | 34 | 2014 |
| Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors M Cigrovski Berković, T Catela Ivković, J Marout, V Zjačić-Rotkvić, ... DNA and cell biology 31 (4), 531-536, 2012 | 30 | 2012 |
| Self-reported hypoglycaemia: a global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study K Khunti, S Alsifri, R Aronson, MC Berkovic, C Enters-Weijnen, T Forsen, ... Diabetologia 57, S201-S202, 2014 | 28 | 2014 |
| Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure PG Rotkvić, MC Berković, N Bulj, L Rotkvić, I Ćelap World journal of diabetes 11 (7), 269, 2020 | 26 | 2020 |
| High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) MC Berković, T Čačev, TC Ivković, J Marout, M Ulamec, V Zjačić-Rotkvić, ... Molecular and cellular endocrinology 425, 61-68, 2016 | 25 | 2016 |
| Obesity paradox in chronic liver diseases: product of bias or a real thing? IB Curcic, MC Berkovic, L Kuna, H Roguljic, R Smolic, SC Varzic, LV Jukic, ... Journal of clinical and translational hepatology 7 (3), 275, 2019 | 24 | 2019 |
| Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications JVL Ogresta D, Mrzljak A, Cigrovski Berkovic M, Bilic-Curcic I ... Journal of Clinical and Translational Hepatology 2022, 2022 | 23 | 2022 |
| Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies U Pedersen‐Bjergaard, S Alsifri, R Aronson, MC Berković, G Galstyan, ... Diabetes, Obesity and Metabolism 21 (4), 844-853, 2019 | 21 | 2019 |
| Minireview: are SGLT2 inhibitors heart savers in diabetes? P Grubić Rotkvić, M Cigrovski Berković, N Bulj, L Rotkvić Heart failure reviews 25 (6), 899-905, 2020 | 20 | 2020 |
Ines Bilic-ĆurčićIzv. prof . na Katedri za farmakologiju, Sveučilište J.J.StrossmayerVerified email at mefos.hr
